- 2021 (4) ▼
- 2020 (65) ▼
- 2019 (41) ▼
- 2018 (21) ▼
If you were unable to attend last month’s webinar about the latest developments in gene therapy for Gaucher treatment, we are delighted to share the recording which presented AVROBIO’s lentiviral investigational gene therapy, an ex vivo gene therapy approach for Type 1 Gaucher disease.
Thanks go to Chris Mason, Chief Scientific Officer, who presented on behalf of AVROBIO and to Professor Tim Cox who moderated the call for us.
Do check out our website for our full schedule of virtual meetings and educational webinars.